Top Markets
Coin of the day
Kinnate Biopharma Inc. Kinnate Biopharma Inc.

Kinnate Biopharma Inc.

KNTE
Rang în acțiuni #21072
Kinnate Biopharma Inc. is a U.S.-based biopharmaceutical company primarily... Kinnate Biopharma Inc. is a U.S.-based biopharmaceutical company primarily focused on identifying and advancing small-molecule drugs that target kinase enzymes to treat cancers defined by specific genetic markers. The company's product pipeline includes: KIN-2787: An inhibitor of rapidly accelerated fibrosarcoma (RAF), currently being developed to treat patients with lung cancer, melanoma, and other forms of solid tumors. KIN-3248: A small-molecule kinase inhibitor designed to counteract cancer-associated genetic mutations in the fibroblast growth factor receptors, specifically FGFR2 and FGFR3. KIN004 Program: This program encompasses early-stage small-molecule research, including a Cyclin-Dependent Kinase 12 (CDK12) inhibitor. Established in 2018, Kinnate Biopharma Inc. maintains its headquarters in San Francisco, California. It was formerly a division of Fount Therapeutics, LLC.
Preț acțiune
$2.65
Ultima sincronizare: 2024-04-03
Capitalizare de piață
$115.71M
Schimbare (1 zi)
0.00%
Schimbare (1 an)
0.00%
Țară
US
Tranzacționează Kinnate Biopharma Inc. (KNTE)

Categorie

Istoric al prețului acțiunii pentru Kinnate Biopharma Inc. (KNTE)
Cel mai mare preț de închidere: $2.65 pe 2024-04-01

Cel mai mic preț de închidere: $40.13 pe 2020-12-01
Istoric al prețului acțiunii pentru Kinnate Biopharma Inc. din 2020 până în 2026
Evoluția anuală a prețului acțiunii
An Performanță
2024 15.54%
2023 -63.61%
2022 -64.96%
2021 -55.12%
2020 0.00%
Prețul acțiunii pentru companii similare sau concurente
Companie Preț acțiune Variație 1an% Țara
$547.71 38.62%
US
$1.04K 58.06%
NL
$145.75 437.43%
US
$118.70 -15.60%
AU
$770.19 8.98%
CH